About Event

The targeted radiotherapies space has been experiencing huge positivity with phenomenal clinical results, huge buyouts, and large supply deals, and with the approval of Lutathera, the space is at such a high! But for the space to continue making progress, we need to ensure we can overcome the biggest bottleneck restricting the field which is the challenging manufacturing and supply chain of these drugs.

For the first time ever, a targeted global audience united in one place at the first and only Targeted Radiopharmaceuticals Manufacturing and Supply Chain Summit which deep-dived into how the industry leaders overcome radioisotope supply issues by designing and scaling novel radioisotope reactors and generators, identifying the exotic radioisotopes that have similar features to Lutetium and Actinium to help strategic source or produce radionuclides of the highest quality, looking into ways to improve the transparency of order status and knowing how to deal with potential hurdles to make ensure your drugs make it to patients on time.

Building and designing your facility to be as agile as possible strengthens your ability to overcome supply chain challenges and make the most of scarce resources.

Who you missed:

TRP p3 (1)